Literature DB >> 2436703

Predictive value of plasma human chorionic gonadotrophin beta subunit in diagnosing ectopic pregnancy after in vitro fertilisation and embryo transfer.

S H Okamoto, D L Healy, L M Morrow, P A Rogers, A O Trounson, E C Wood.   

Abstract

A study was conducted aimed at establishing a range of plasma concentrations of the beta subunit of human chorionic gonadotrophin that might predict ectopic pregnancy after in vitro fertilisation and embryo transfer. From May 1984 to February 1986, 161 consecutive pregnancies at the Monash University in vitro fertilisation unit were analysed by determining plasma beta human chorionic gonadotrophin concentrations between two and 10 weeks after oocyte collection. Eighty eight ongoing singleton pregnancies, 25 multiple pregnancies, 27 first trimester spontaneous abortions, 12 anembryonic pregnancies, and nine ectopic pregnancies resulted from these conception cycles. When compared with values for ongoing singleton pregnancies two weeks after oocyte collection plasma beta human chorionic gonadotrophin concentrations in ectopic pregnancies were significantly lower (p less than 0.05; Wilcoxon rank sum test). Two weeks after oocyte collection all plasma beta human chorionic gonadotrophin concentrations in the set of ectopic pregnancies were below 30.6 IU/l, which corresponded to the lower quartile (25th percentile) of beta human chorionic gonadotrophin concentrations in ongoing singleton pregnancies. The beta human chorionic gonadotrophin concentration corresponding to the lower quartile of ongoing singleton pregnancies at each week of gestation was used to derive the predictive value of various statistics in detecting ectopic pregnancy in patients after in vitro fertilisation. The sensitivity, specificity, predictive value of a positive result, predictive value of a negative result, and efficiency of a single plasma beta human chorionic gonadotrophin concentration in predicting ectopic pregnancy were 100%, 68.1%, 16.7%, 100%, and 70%, respectively, two weeks after oocyte collection. These results suggest that a single determination of the plasma beta human chorionic gonadotrophin concentration beginning 14 days after oocyte collection is clinically useful in predicting the outcome of pregnancy achieved by in vitro fertilisation. Ectopic pregnancy after in vitro fertilisation is more likely when beta human chorionic gonadotrophin concentration is below the lower quartile of values in ongoing singleton pregnancies achieved by the technique.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2436703      PMCID: PMC1245730          DOI: 10.1136/bmj.294.6573.667

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  20 in total

1.  An analysis of plasma estradiol concentrations during clomiphene citrate-human menopausal gonadotropin stimulation in an in vitro fertilization-embryo transfer program.

Authors:  S Okamoto; D L Healy; D T Howlett; P A Rogers; J F Leeton; A O Trounson; E C Wood
Journal:  J Clin Endocrinol Metab       Date:  1986-09       Impact factor: 5.958

2.  Health, normality, and the ghost of Gauss.

Authors:  L R Elveback; C L Guillier; F R Keating
Journal:  JAMA       Date:  1970-01-05       Impact factor: 56.272

3.  Incidence of ectopic pregnancy in Rochester, Minnesota, 1950-1981.

Authors:  J H Strathy; C B Coulam; P Marchbanks; J F Annegers
Journal:  Obstet Gynecol       Date:  1984-07       Impact factor: 7.661

4.  Plasma concentrations of human chorionic gonadotropin from the time of implantation until the second week of pregnancy.

Authors:  E A Lenton; L M Neal; R Sulaiman
Journal:  Fertil Steril       Date:  1982-06       Impact factor: 7.329

5.  Delayed appearance of plasmatic chorionic gonadotropin in pregnancies after in vitro fertilization and embryo transfer.

Authors:  Y Englert; M Roger; J Belaisch-Allart; M Jondet; R Frydman; J Testart
Journal:  Fertil Steril       Date:  1984-12       Impact factor: 7.329

6.  Discriminatory hCG zone: its use in the sonographic evaluation for ectopic pregnancy.

Authors:  N Kadar; G DeVore; R Romero
Journal:  Obstet Gynecol       Date:  1981-08       Impact factor: 7.661

7.  Chromosome assignment of genes encoding the alpha and beta subunits of glycoprotein hormones in man and mouse.

Authors:  S L Naylor; W W Chin; H M Goodman; P A Lalley; K H Grzeschik; A Y Sakaguchi
Journal:  Somatic Cell Genet       Date:  1983-11

8.  Embryonic development and blastocyst implantation following in vitro fertilization and embryo transfer.

Authors:  A Lopata; M Martin; K Oliva; I Johnston
Journal:  Fertil Steril       Date:  1982-12       Impact factor: 7.329

9.  Deaths from ectopic pregnancy, United States, 1979 to 1980.

Authors:  S F Dorfman
Journal:  Obstet Gynecol       Date:  1983-09       Impact factor: 7.661

10.  Pregnancies in humans by fertilization in vitro and embryo transfer in the controlled ovulatory cycle.

Authors:  A O Trounson; J F Leeton; C Wood; J Webb; J Wood
Journal:  Science       Date:  1981-05-08       Impact factor: 47.728

View more
  4 in total

1.  Life-threatening rupture of an interstitial ectopic pregnancy arising from oocyte donation: failure of early detection by quantitive human chorionic gonadotropin (hCG) and progesterone estimation.

Authors:  W Ledger; A Clark; G Olesnicky; R Norman
Journal:  J Assist Reprod Genet       Date:  1992-06       Impact factor: 3.412

2.  Measurement of human chorionic gonadotropin during early pregnancy: a comparison of two immunoradiometric assays.

Authors:  P L Matson; M C Newman; D Morroll; S A Troup; B A Lieberman
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-06

3.  Ectopic pregnancies after in vitro fertilization and embryo transfer.

Authors:  E Pyrgiotis; K M Sultan; G S Neal; H C Liu; J A Grifo; Z Rosenwaks
Journal:  J Assist Reprod Genet       Date:  1994-02       Impact factor: 3.412

4.  Two-step diagnosis of bilateral ectopic pregnancy after in vitro fertilization.

Authors:  J Hugues; B Olszewska; P Dauvergne; S Bulwa; I Cedrin-Durnerin
Journal:  J Assist Reprod Genet       Date:  1995-08       Impact factor: 3.412

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.